Skip to main content
ROSSARI BIOTECH LIMITED logo

ROSSARI BIOTECH LIMITED — Investor Relations & Filings

Ticker · ROSSARI ISIN · INE02A801020 LEI · 335800R7XFRR8ZTHBQ25 BSE.NS Manufacturing
Open in API
Filings indexed 529 across all filing types
Latest filing 2022-08-09 Regulatory Filings
Country IN India
Listing BSE.NS ROSSARI

About ROSSARI BIOTECH LIMITED

https://www.rossari.com/

Rossari Biotech Limited is a specialty chemicals manufacturer focused on providing sustainable and innovative solutions across diverse sectors. The company operates through three primary business segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals, and Animal Health and Nutrition. In the HPPC segment, it supplies essential ingredients for detergents, soaps, paints, and water treatment applications. Its textile division offers a comprehensive range of chemicals for the entire textile value chain, including pre-treatment, dyeing, and finishing processes. Additionally, the company provides high-quality feed additives and supplements for the poultry and livestock industries. Driven by robust research and development capabilities, Rossari Biotech emphasizes eco-friendly chemistry and customized formulations to meet specific client requirements. With advanced manufacturing facilities, the company serves a global clientele, maintaining a strong focus on operational excellence.

Recent filings

Filing Released Lang Actions
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short communication (1350 characters) notifying the availability of the audio recording of an earnings conference call for Q1 & FY 23. It references Regulation 30 of SEBI and provides a link to the recording on the company's website. There is no substantive financial data or detailed transcript included in the text. The document serves as an announcement or intimation rather than the actual earnings release or call transcript. According to the 'Menu vs Meal' rule, such short notices about availability of recordings or reports are not the reports themselves. Therefore, the document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2022-08-09 English
Newspaper Advertisements
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the publication of extracts of consolidated unaudited financial results for the quarter ended June 30, 2022. It references compliance with SEBI regulations and mentions the publication of financial results extracts in newspapers. The document does not contain full financial statements or detailed financial analysis but is an announcement about the publication of financial results extracts. The length is about 15,000 characters, but the content is primarily an announcement letter with attached newspaper extracts. Therefore, this is not the full interim or quarterly report but an announcement related to financial results publication. According to the rules, such announcements are best classified as Regulatory Filings (RNS) because it is a compliance announcement about financial results publication, not the report itself.
2022-08-08 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated August 7, 2022, announcing the financial results for the quarter ended June 30, 2022 (Q1 FY23). It contains detailed financial performance data including revenues, EBITDA, PAT, and EPS for both consolidated and standalone results. It also includes management commentary on the quarter's performance and business outlook. The document is not a full quarterly report but rather a summary announcement of quarterly financial results. It is not an earnings release in the strict sense (which typically is a brief headline announcement), but rather a press release with detailed financial highlights. Given the detailed financial data and commentary, this fits best under the category of Earnings Release (ER). Q1 2023
2022-08-07 English
Investor Presentation
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Q1 FY23 Results Presentation' and contains detailed financial data for the quarter ended June 30, 2022, including revenue, EBITDA, PAT, segment-wise details, and management commentary. It is a comprehensive presentation of quarterly financial results with analysis and outlook. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The content matches the characteristics of an Interim / Quarterly Report, as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Therefore, the appropriate classification is 'IR' (Interim / Quarterly Report). Q1 2023
2022-08-07 English
ESOP/ESPS/SBEB Scheme
Share Issue/Capital Change Classification · 100% confidence The document is an official communication from Rossari Biotech Limited to stock exchanges regarding the allotment of equity shares under the Employee Stock Option Plan (ESOP) 2019. It details the number of shares allotted, the exercise price, the increase in paid-up capital, and compliance with SEBI regulations. The document is an announcement of a share allotment event related to employee stock options, which is a capital change event. It is not a full financial report, audit, or earnings release, nor is it a meeting material or voting result. The document fits the category of Share Issue/Capital Change announcements as it informs about new shares issued and changes in capital structure.
2022-08-06 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement dated August 6, 2022, from Rossari Biotech Limited regarding the outcome of a Board Meeting. It specifically states that the Board approved the Unaudited Financial Results for the quarter ended June 30, 2022, which is a typical characteristic of an Interim / Quarterly Report. The document includes detailed financial tables with income, expenses, profit, and other comprehensive income for the quarter, as well as notes and an Independent Auditor's Review Report on the interim financial results. The presence of detailed financial data and the auditor's limited review confirms this is a substantive financial report for a period shorter than a full fiscal year. It is not merely an announcement of a report or a certification letter, but the actual interim financial results document. Therefore, the correct classification is Interim / Quarterly Report (IR).
2022-08-06 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.